Recruiting NA INTERVENTIONAL 7-arm NCT05044962

Kuwa Free! - Live Free!

Co-benefits of Co-delivery of Long-acting Antiretrovirals and Contraceptives

Sponsor: Indiana University

Conditions Contraception Drug-drug Interaction HIV Infections

Interventions Cabotegravir/ Rilpivirine Etonogestrel (ETG) implant Intramuscular depo-medroxyprogesterone acetate (IM DMPA) Levonorgestrel NNRTI, PI, or INSTI-containing 1st or 2nd line ART regimens

Updated 7 times since 2021 Last updated: Apr 7, 2025 Started: Nov 26, 2021 Primary completion: Mar 31, 2026 Completion: Mar 31, 2026

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Contraception and Drug-drug Interaction and is currently actively recruiting participants. Indiana University leads this study, which shows 7 recorded versions since 2021 — indicating limited longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.

Status Flow

Change History

7 versions recorded

May 2025 — Present [monthly]

Recruiting NA
Sep 2024 — May 2025 [monthly]

Recruiting NA
Jul 2024 — Sep 2024 [monthly]

Recruiting NA
May 2024 — Jul 2024 [monthly]

Recruiting NA
Jun 2023 — May 2024 [monthly]

Recruiting NA

▶ Show 2 earlier versions

Apr 2022 — Jun 2023 [monthly]

Recruiting NA

Status: Not Yet Recruiting → Recruiting
Oct 2021 — Apr 2022 [monthly]

Not Yet Recruiting NA

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Indiana University
Moi Teaching and Referral Hospital
National Institute of Allergy and Infectious Diseases (NIAID)
University of Alabama at Birmingham
University of Nebraska

Data source: University of Alabama at Birmingham

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Eldoret, Kenya